Julander JG - Search Results

1

Therapeutic and prophylactic treatment with a virus-specific antibody is highly effective in rodent models of Chikungunya infection and disease.

Julander JG, Anderson N, Haese N, Andoh T, Streblow DN, Cortez P, Carter K, Marniquet X, Watson H, Mandron M. Julander JG, et al. Antiviral Res. 2022 Jun;202:105295. doi: 10.1016/j.antiviral.2022.105295. Epub 2022 Mar 24. Antiviral Res. 2022. PMID: 35339583

2

Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus.

Julander JG, Sidwell RW, Morrey JD. Julander JG, et al. Antiviral Res. 2002 Jul;55(1):27-40. doi: 10.1016/s0166-3542(01)00223-6. Antiviral Res. 2002. PMID: 12076749

3

Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus.

Julander JG, Colonno RJ, Sidwell RW, Morrey JD. Julander JG, et al. Antiviral Res. 2003 Aug;59(3):155-61. doi: 10.1016/s0166-3542(03)00109-8. Antiviral Res. 2003. PMID: 12927305

4

Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.

Morrey JD, Day CW, Julander JG, Blatt LM, Smee DF, Sidwell RW. Morrey JD, et al. Among authors: julander jg. Antivir Chem Chemother. 2004 Mar;15(2):101-9. doi: 10.1177/095632020401500202. Antivir Chem Chemother. 2004. PMID: 15185728 Free article.

5

Modeling hamsters for evaluating West Nile virus therapies.

Morrey JD, Day CW, Julander JG, Olsen AL, Sidwell RW, Cheney CD, Blatt LM. Morrey JD, et al. Among authors: julander jg. Antiviral Res. 2004 Jul;63(1):41-50. doi: 10.1016/j.antiviral.2004.02.005. Antiviral Res. 2004. PMID: 15196819

6

Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival.

Julander JG, Winger QA, Olsen AL, Day CW, Sidwell RW, Morrey JD. Julander JG, et al. Antiviral Res. 2005 Feb;65(2):79-85. doi: 10.1016/j.antiviral.2004.10.005. Antiviral Res. 2005. PMID: 15708634

7

Error-prone replication of West Nile virus caused by ribavirin.

Day CW, Smee DF, Julander JG, Yamshchikov VF, Sidwell RW, Morrey JD. Day CW, et al. Among authors: julander jg. Antiviral Res. 2005 Jul;67(1):38-45. doi: 10.1016/j.antiviral.2005.04.002. Antiviral Res. 2005. PMID: 15919121

8

Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model.

Julander JG, Morrey JD, Blatt LM, Shafer K, Sidwell RW. Julander JG, et al. Antiviral Res. 2007 Feb;73(2):140-6. doi: 10.1016/j.antiviral.2006.08.008. Epub 2006 Sep 22. Antiviral Res. 2007. PMID: 17049380 Free PMC article.

9

Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection.

Julander JG, Judge JW, Olsen AL, Rosenberg B, Schafer K, Sidwell RW. Julander JG, et al. Antiviral Res. 2007 Jul;75(1):14-9. doi: 10.1016/j.antiviral.2006.11.005. Epub 2006 Dec 4. Antiviral Res. 2007. PMID: 17210189 Free PMC article.

10

Activity of T-1106 in a hamster model of yellow Fever virus infection.

Julander JG, Furuta Y, Shafer K, Sidwell RW. Julander JG, et al. Antimicrob Agents Chemother. 2007 Jun;51(6):1962-6. doi: 10.1128/AAC.01494-06. Epub 2007 Apr 9. Antimicrob Agents Chemother. 2007. PMID: 17420215 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters